SCHEMBL2499367

SCHEMBL2499367

C1=CC2=NN=CC2=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17838918 0.67
SCHEMBL9559243 0.65
SCHEMBL1533841 0.65 PPARA (0.32)
SCHEMBL10772455 0.61
SCHEMBL11786643 0.61
SCHEMBL8691695 0.61
SCHEMBL9220672 0.58
SCHEMBL6869661 0.58
SCHEMBL7113896 0.57
SCHEMBL1371425 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050800-A1 PROTEIN PHOSPHATASE AGONIST AND USE 南京中瑞药业有限公司 2024-03-14 WO claimed
US-7288122-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-10-30 US claimed
US-7285138-B2 Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore L'OREAL, S.A. (FR) 2007-10-23 US claimed
US-7282069-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-10-16 US claimed
US-7208586-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-04-24 US claimed
CN-1760192-A Cationic diazo compounds, compositions comprising them, methods for dyeing and kit OREAL (FR) 2006-04-19 CN claimed
EP-1637566-A1 Cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit L'OREAL (FR) 2006-03-22 EP claimed
EP-1634926-A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit L'OREAL (FR) 2006-03-15 EP claimed
CN-1743382-A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor OREAL (FR) 2006-03-08 CN claimed
CN-1737064-A Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore OREAL (FR) 2006-02-22 CN claimed
CN-1733757-A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor OREAL (FR) 2006-02-15 CN claimed
US-20060021162-A1 Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore L'OREAL S.A. (FR) 2006-02-02 US claimed
US-20060016025-A1 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2006-01-26 US claimed
EP-1619221-A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit L'OREAL (FR) 2006-01-25 EP claimed
EP-1619220-A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit L'Oreal-D.I.P.I. (FR) 2006-01-25 EP claimed
US-20060005324-A1 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2006-01-12 US claimed
US-20060005327-A1 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2006-01-12 US claimed
US-6608058-B2 Therapeutic composition for hepatitis B, hepatitis C, or acquired immune deficiency syndrome DONG WHA PHARM. IND. CO., LTD. (KR) 2003-08-19 US claimed
US-20030092709-A1 6-Methylnicotinamide derivatives as antiviral agents DONG WHA PHARM. CO., LTD. (KR) 2003-05-15 US claimed
WO-2001078648-A2 6-METHYLNICOTINAMIDE DERIVATIVES AS ANTIVIRAL AGENTS DONG WHA PHARM. IND. CO., LTD. (KR) 2001-10-25 WO claimed